CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-08 | POLEWACZYK JAMES F Executive Vice President | Grant or award · Restricted Stock Unit | +880 | 2,989 | ||
| 2023-02-08 | MCKEON BRIAN P Executive VP & CFO | Grant or award · Non-Qualified Stock Option (right-to-buy) | +8,811 | 8,811 | ||
| 2023-02-08 | MCKEON BRIAN P Executive VP & CFO | Grant or award · Incentive Stock Option (right-to-buy) | +201 | 201 | ||
| 2023-02-08 | MCKEON BRIAN P Executive VP & CFO | Grant or award · Restricted Stock Unit | +1,231 | 5,824 | ||
| 2023-02-08 | MAZELSKY JONATHAN JAY President & CEO | Grant or award · Non-Qualified Stock Option (right-to-buy) | +21,256 | 21,256 | ||
| 2023-02-08 | MAZELSKY JONATHAN JAY President & CEO | Grant or award · Premium Non-Qualified Stock Option (right-to-buy) | +12,181 | 12,181 | ||
| 2023-02-08 | MAZELSKY JONATHAN JAY President & CEO | Grant or award · Incentive Stock Option (right-to-buy) | +201 | 201 | ||
| 2023-02-08 | MAZELSKY JONATHAN JAY President & CEO | Grant or award · Restricted Stock Unit | +4,398 | 14,388 | ||
| 2023-02-08 | Lane Michael Executive Vice President | Grant or award · Non-Qualified Stock Option (right-to-buy) | +6,236 | 6,236 | ||
| 2023-02-08 | Lane Michael Executive Vice President | Grant or award · Incentive Stock Option (right-to-buy) | +201 | 201 | ||
| 2023-02-08 | Lane Michael Executive Vice President | Grant or award · Restricted Stock Unit | +880 | 3,082 | ||
| 2023-02-08 | Johnson Michael Perkins Senior Vice President | Grant or award · Non-Qualified Stock Option (right-to-buy) | +4,346 | 4,346 | ||
| 2023-02-08 | Johnson Michael Perkins Senior Vice President | Grant or award · Incentive Stock Option (right-to-buy) | +804 | 804 | ||
| 2023-02-08 | Johnson Michael Perkins Senior Vice President | Grant or award · Restricted Stock Unit | +704 | 4,086 | ||
| 2023-02-08 | Hunt Nimrata Executive Vice President | Grant or award · Non-Qualified Stock Option (right-to-buy) | +5,868 | 5,868 | ||
| 2023-02-08 | Hunt Nimrata Executive Vice President | Grant or award · Incentive Stock Option (right-to-buy) | +201 | 201 | ||
| 2023-02-08 | Hunt Nimrata Executive Vice President | Grant or award · Restricted Stock Unit | +1,508 | 3,531 | ||
| 2023-02-08 | Hunt Nimrata Executive Vice President | Grant or award · Restricted Stock Unit | +829 | 4,360 | ||
| 2023-01-30 | JUNIUS DANIEL M Director | Grant or award | +14 | $482.95 | $7K | 2,982 |
| 2022-12-14 | AYERS JONATHAN W Director | Gift | −2,400 | 168,020 |
Page 51 of 52 · 1,036 trades